Search

everythinglearnresearchcommunity

for

Search:↓

The letter is skeptical about the effectiveness of anti-androgen therapy for COVID-19 and calls for strong evidence from clinical trials.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

The G allele of IFITM3 rs12252 is linked to more severe COVID-19.

Targeted interventions based on gender, education, and age can improve COVID-19 healthcare responses.

Many healthcare workers who had Covid-19 suffer from long-term symptoms like hair loss and fatigue, especially women.

Zinc acetate hydrate may help reduce fatigue and hair loss in post-COVID-19 patients.

Quality of life improved after COVID-19, but ongoing health support is needed.

Vaccination is crucial for managing Covid-19 despite new virus strains.

A woman with ectopic Cushing's syndrome and COVID-19 passed away despite treatment.

More clinical trials are needed to confirm if plant-based products can effectively treat COVID-19.

Natural plant compounds may offer safer COVID-19 treatments with fewer side effects.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Anabolic steroid users may face higher risk of severe COVID-19.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

Beau's lines on fingernails might indicate past severe COVID-19 and risk of reinfection.

The pandemic changed how often certain skin conditions were diagnosed.

Cepharanthine is safe but not clearly effective in speeding up COVID-19 recovery.

Nursing staff's mental health was affected during the COVID-19 pandemic.

Hormonal status from androgen deprivation therapy may affect COVID-19 severity in men.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

A woman experienced severe symptoms, including hair loss, after a COVID-19 vaccine, suggesting a possible autoimmune reaction.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Physical activity increased, but sedentary behavior also rose, especially in men.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

The study suggests pandemic stress might worsen or trigger hair loss problems.

High-dose vitamin D3 does not improve symptoms or quality of life in COVID-19 patients after one year.

COVID-19 can lead to different skin symptoms and might trigger autoimmune diseases in genetically susceptible people.

COVID-19 can cause skin problems in children.

COVID-19 has increased hair loss, but many patients see regrowth within months.

COVID-19 vaccines do not increase the risk of alopecia areata.